What is Altimmune's investment proceeds?

Altimmune (ALT) reported investment proceeds of $39.62M in Q1 2026.

How has Altimmune's investment proceeds changed year-over-year?

Altimmune's investment proceeds increased by 4.2% year-over-year, from $38.04M to $39.62M.

What is the long-term trend for Altimmune's investment proceeds?

Over 3 years (2021 to 2025), Altimmune's investment proceeds has grown at a 12.5% compound annual growth rate (CAGR), from $107.43M to $152.99M.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

Altimmune ALT Investment Proceeds

Investment Proceeds at other companies

Madrigal Pharmaceuticals, Inc.MDGL

$353.87M+20.1%

Viking TherapeuticsVKTX

$126.63M-57.2%

Delcath SystemsDCTH

$15.81M+213%

Mirum Pharmaceuticals, Inc.MIRM

$33.89M+94.4%

Beam TherapeuticsBEAM

$181.29M-16.5%

PTC TherapeuticsPTCT

$376.36M+175%

Other financials

Income statement

See full

Revenue$26.0K+420%

Operating income-$24.2M-11.1%

Net income-$22.6M-15.3%

EPS (diluted)-$0.18+30.8%

Balance sheet

See full

Cash & equivalents$97.6M+98.7%

Total debt$34.8M+14,092%

Total equity$284.0M+99.8%

Total assets$335.6M+113%

Cash flow

See full

Operating cash flow-$20.9M-24.4%

CapEx$21.0K—

Free cash flow-$21.0M—

Valuation

See full

Market cap$558.14M-2.1%

Enterprise value$495.27M-5.0%

P/S13,613.2×-24,380×

Profitability

See full

Operating margin-230,461%-82,087pp

Net margin-214,861%-76,057pp

FCF margin-17,806.8%-110,030pp

Returns & leverage

See full

Return on equity-42.7%-8.7pp

Debt / equity0.1×+0.1×

Current ratio29.6×+13.7×

Where this comes from

Reported directly by Altimmune in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.

The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Altimmune's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Altimmune's investment proceeds?: Altimmune (ALT) reported investment proceeds of $39.62M in Q1 2026.
How has Altimmune's investment proceeds changed year-over-year?: Altimmune's investment proceeds increased by 4.2% year-over-year, from $38.04M to $39.62M.
What is the long-term trend for Altimmune's investment proceeds?: Over 3 years (2021 to 2025), Altimmune's investment proceeds has grown at a 12.5% compound annual growth rate (CAGR), from $107.43M to $152.99M.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.